White House team reacts to FDA report on rapid COVID test sensitivity: PCR, antigen tests 'critical tools'

December 29, 2021

White House team reacts to FDA report on rapid COVID test sensitivity: PCR, antigen tests 'critical tools'
By Julia Musto

Members of the White House COVID-19 response team reacted Wednesday to new guidance from the Food and Drug Administration (FDA) on the sensitivity of rapid antigen tests, telling reporters that the tests' usefulness amid the pandemic has not altered.